BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 9580660)

  • 1. Characterization of molecular defects in xeroderma pigmentosum group F in relation to its clinically mild symptoms.
    Matsumura Y; Nishigori C; Yagi T; Imamura S; Takebe H
    Hum Mol Genet; 1998 Jun; 7(6):969-74. PubMed ID: 9580660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Xeroderma pigmentosum group F protein binds to Eg5 and is required for proper mitosis: implications for XP-F and XFE.
    Tan LJ; Saijo M; Kuraoka I; Narita T; Takahata C; Iwai S; Tanaka K
    Genes Cells; 2012 Mar; 17(3):173-85. PubMed ID: 22353549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complete restoration of normal DNA repair characteristics in group F xeroderma pigmentosum cells by over-expression of transfected XPF cDNA.
    Yagi T; Matsumura Y; Sato M; Nishigori C; Mori T; Sijbers AM; Takebe H
    Carcinogenesis; 1998 Jan; 19(1):55-60. PubMed ID: 9472693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mislocalization of XPF-ERCC1 nuclease contributes to reduced DNA repair in XP-F patients.
    Ahmad A; Enzlin JH; Bhagwat NR; Wijgers N; Raams A; Appledoorn E; Theil AF; J Hoeijmakers JH; Vermeulen W; J Jaspers NG; Schärer OD; Niedernhofer LJ
    PLoS Genet; 2010 Mar; 6(3):e1000871. PubMed ID: 20221251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sensitivity of group F xeroderma pigmentosum cells to UV and mitomycin C relative to levels of XPF and ERCC1 overexpression.
    Yagi T; Katsuya A; Koyano A; Takebe H
    Mutagenesis; 1998 Nov; 13(6):595-9. PubMed ID: 9862190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Xeroderma pigmentosum group F caused by a defect in a structure-specific DNA repair endonuclease.
    Sijbers AM; de Laat WL; Ariza RR; Biggerstaff M; Wei YF; Moggs JG; Carter KC; Shell BK; Evans E; de Jong MC; Rademakers S; de Rooij J; Jaspers NG; Hoeijmakers JH; Wood RD
    Cell; 1996 Sep; 86(5):811-22. PubMed ID: 8797827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deep intronic founder mutations identified in the
    Senju C; Nakazawa Y; Oso T; Shimada M; Kato K; Matsuse M; Tsujimoto M; Masaki T; Miyazaki Y; Fukushima S; Tateishi S; Utani A; Murota H; Tanaka K; Mitsutake N; Moriwaki S; Nishigori C; Ogi T
    Proc Natl Acad Sci U S A; 2023 Jul; 120(27):e2217423120. PubMed ID: 37364129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Homozygous R788W point mutation in the XPF gene of a patient with xeroderma pigmentosum and late-onset neurologic disease.
    Sijbers AM; van Voorst Vader PC; Snoek JW; Raams A; Jaspers NG; Kleijer WJ
    J Invest Dermatol; 1998 May; 110(5):832-6. PubMed ID: 9579555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Xeroderma pigmentosum patients belonging to complementation group F and efficient liquid-holding recovery of ultraviolet damage.
    Nishigori C; Fujisawa H; Uyeno K; Kawaguchi T; Takebe H
    Photodermatol Photoimmunol Photomed; 1991 Aug; 8(4):146-50. PubMed ID: 1814424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mapping of interaction domains between human repair proteins ERCC1 and XPF.
    de Laat WL; Sijbers AM; Odijk H; Jaspers NG; Hoeijmakers JH
    Nucleic Acids Res; 1998 Sep; 26(18):4146-52. PubMed ID: 9722633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Xeroderma pigmentosum complementation group F: Report of a case and review of Japanese patients.
    Tofuku Y; Nobeyama Y; Kamide R; Moriwaki S; Nakagawa H
    J Dermatol; 2015 Sep; 42(9):897-9. PubMed ID: 26010807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The age-related expression decline of ERCC1 and XPF for forensic age estimation: A preliminary study.
    Deng XD; Gao Q; Zhang W; Zhang B; Ma Y; Zhang LX; Muer C; Xie Y; Liu Y
    J Forensic Leg Med; 2017 Jul; 49():15-19. PubMed ID: 28486142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemosensitivity of primary human fibroblasts with defective unhooking of DNA interstrand cross-links.
    Clingen PH; Arlett CF; Hartley JA; Parris CN
    Exp Cell Res; 2007 Feb; 313(4):753-60. PubMed ID: 17188678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. True XP group E patients have a defective UV-damaged DNA binding protein complex and mutations in DDB2 which reveal the functional domains of its p48 product.
    Rapić-Otrin V; Navazza V; Nardo T; Botta E; McLenigan M; Bisi DC; Levine AS; Stefanini M
    Hum Mol Genet; 2003 Jul; 12(13):1507-22. PubMed ID: 12812979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Malfunction of nuclease ERCC1-XPF results in diverse clinical manifestations and causes Cockayne syndrome, xeroderma pigmentosum, and Fanconi anemia.
    Kashiyama K; Nakazawa Y; Pilz DT; Guo C; Shimada M; Sasaki K; Fawcett H; Wing JF; Lewin SO; Carr L; Li TS; Yoshiura K; Utani A; Hirano A; Yamashita S; Greenblatt D; Nardo T; Stefanini M; McGibbon D; Sarkany R; Fassihi H; Takahashi Y; Nagayama Y; Mitsutake N; Lehmann AR; Ogi T
    Am J Hum Genet; 2013 May; 92(5):807-19. PubMed ID: 23623389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Defects in the DNA repair and transcription gene ERCC2 in the cancer-prone disorder xeroderma pigmentosum group D.
    Takayama K; Salazar EP; Lehmann A; Stefanini M; Thompson LH; Weber CA
    Cancer Res; 1995 Dec; 55(23):5656-63. PubMed ID: 7585650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular genetic analysis of 16 XP-C patients from Germany: environmental factors predominately contribute to phenotype variations.
    Schäfer A; Hofmann L; Gratchev A; Laspe P; Schubert S; Schürer A; Ohlenbusch A; Tzvetkov M; Hallermann C; Reichrath J; Schön MP; Emmert S
    Exp Dermatol; 2013 Jan; 22(1):24-9. PubMed ID: 23173980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutations in the XPD gene leading to xeroderma pigmentosum symptoms.
    Kobayashi T; Kuraoka I; Saijo M; Nakatsu Y; Tanaka A; Someda Y; Fukuro S; Tanaka K
    Hum Mutat; 1997; 9(4):322-31. PubMed ID: 9101292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repair protein persistence at DNA lesions characterizes XPF defect with Cockayne syndrome features.
    Sabatella M; Theil AF; Ribeiro-Silva C; Slyskova J; Thijssen K; Voskamp C; Lans H; Vermeulen W
    Nucleic Acids Res; 2018 Oct; 46(18):9563-9577. PubMed ID: 30165384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repair of damaged DNA by extracts from a xeroderma pigmentosum complementation group A revertant and expression of a protein absent in its parental cell line.
    Jones CJ; Cleaver JE; Wood RD
    Nucleic Acids Res; 1992 Mar; 20(5):991-5. PubMed ID: 1549511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.